NICE technology appraisal guidance
Issued: May 2008
TA142

Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta142

Important information about this guidance

This guidance has been replaced by NICE technology appraisal guidance 323.